Cargando…
Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update
Autores principales: | Borghi, Claudio, Domienik-Karłowicz, Justyna, Tykarski, Andrzej, Widecka, Krystyna, Filipiak, Krzysztof J., Jaguszewski, Miłosz J., Narkiewicz, Krzysztof, Mancia, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105060/ https://www.ncbi.nlm.nih.gov/pubmed/33438180 http://dx.doi.org/10.5603/CJ.a2021.0001 |
Ejemplares similares
-
Management of dyslipidemia in Poland: Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. The Fourth Declaration of Sopot
por: Szymański, Filip M., et al.
Publicado: (2022) -
Study of epidemiological aspects of hyperuricemia in Poland
por: Kostka-Jeziorny, Katarzyna, et al.
Publicado: (2019) -
Bivalirudin use in acute coronary syndrome patients undergoing percutaneous coronary interventions in Poland: Clinical update from expert group of the Association on Cardiovascular Interventions of the Polish Cardiac Society
por: Kołtowski, Łukasz, et al.
Publicado: (2019) -
TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice
por: Filipiak, Krzysztof J., et al.
Publicado: (2022) -
Uric acid and xantine-oxidase inhibitors in patients with gout: A re-assessment and an update
por: Borghi, Claudio, et al.
Publicado: (2019)